Rock Creek Pharmaceuticals, Inc. is a pharmaceutical development company. The Company is focused on the discovery, development, and commercialization of therapies for chronic inflammatory disease, neurologic disorders, and behavioral health utilizing its compounds. Its development activities are focused on its lead compound, anatabine citrate. Anatabine citrate is a small molecule, cholinergic agonist, which exhibits